BIOMARKER:

BRIP1 mutation

Entrez ID:

Related biomarkers:

‹

›

BRIP1 mutation BRIP1 mutation	Prostate Cancer Prostate Cancer	BRIP1 mutation BRIP1 mutation	Prostate Cancer Prostate Cancer	olaparib Sensitive: A2 - Guideline	olaparib Sensitive: A2 - Guideline
BRIP1 mutation BRIP1 mutation	Ovarian Cancer Ovarian Cancer	BRIP1 mutation BRIP1 mutation	Ovarian Cancer Ovarian Cancer	olaparib Sensitive: B - Late Trials	olaparib Sensitive: B - Late Trials
BRIP1 mutation BRIP1 mutation	Urothelial Cancer Urothelial Cancer	BRIP1 mutation BRIP1 mutation	Urothelial Cancer Urothelial Cancer	olaparib Sensitive: C2 – Inclusion Criteria	olaparib Sensitive: C2 – Inclusion Criteria
BRIP1 mutation BRIP1 mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	BRIP1 mutation BRIP1 mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	durvalumab Sensitive: C2 – Inclusion Criteria	durvalumab Sensitive: C2 – Inclusion Criteria
BRIP1 mutation BRIP1 mutation	Pancreatic Cancer Pancreatic Cancer	BRIP1 mutation BRIP1 mutation	Pancreatic Cancer Pancreatic Cancer	nivolumab + ABT-888 Sensitive: C3 – Early Trials	nivolumab + ABT-888 Sensitive: C3 – Early Trials
BRIP1 mutation BRIP1 mutation	Colon Cancer Colon Cancer	BRIP1 mutation BRIP1 mutation	Colon Cancer Colon Cancer	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
BRIP1 mutation BRIP1 mutation	Prostate Cancer Prostate Cancer	BRIP1 mutation BRIP1 mutation	Prostate Cancer Prostate Cancer	rucaparib Sensitive: C3 – Early Trials	rucaparib Sensitive: C3 – Early Trials